HRAS and salivary duct carcinoma: HRAS and PIK3CA comutated salivary duct carcinoma usually stain positive for the androgen receptor in immunohistochemistry.19 Antiandrogen therapy was not suggested by the human expert because no immunohistochemistry results were provided.